1 Introduction to Research & Analysis Reports 1.1 Facial Injectable Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Facial Injectable Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Facial Injectable Overall Market Size 2.1 United States Facial Injectable Market Size: 2021 VS 2027 2.2 United States Facial Injectable Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Facial Injectable Players in United States Market 3.2 Top United States Facial Injectable Companies Ranked by Revenue 3.3 United States Facial Injectable Revenue by Companies 3.4 Top 3 and Top 5 Facial Injectable Companies in United States Market, by Revenue in 2020 3.5 Companies Facial Injectable Product Type 3.6 Tier 1, Tier 2 and Tier 3 Facial Injectable Players in United States Market 3.6.1 List of Tier 1 Facial Injectable Companies in United States 3.6.2 List of Tier 2 and Tier 3 Facial Injectable Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Facial Injectable Market Size Markets, 2021 & 2027 4.1.2 Hyaluronic Acid 4.1.3 Collagen 4.1.4 Botulinum Toxin 4.1.5 Polymers 4.1.6 Particles 4.2 By Type - United States Facial Injectable Revenue & Forecasts 4.2.1 By Type - United States Facial Injectable Revenue, 2016-2021 4.2.2 By Type - United States Facial Injectable Revenue, 2022-2027 4.2.3 By Type - United States Facial Injectable Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Facial Injectable Market Size, 2021 & 2027 5.1.2 Hospitals 5.1.3 Clinics 5.1.4 Research 5.1.5 Others 5.2 By Application - United States Facial Injectable Revenue & Forecasts 5.2.1 By Application - United States Facial Injectable Revenue, 2016-2021 5.2.2 By Application - United States Facial Injectable Revenue, 2022-2027 5.2.3 By Application - United States Facial Injectable Revenue Market Share, 2016-2027 6 Facial Injectable Companies Profiles 6.1 Bloomega BioTechnology 6.1.1 Bloomega BioTechnology Company Details 6.1.2 Bloomega BioTechnology Business Overview 6.1.3 Bloomega BioTechnology Facial Injectable Introduction 6.1.4 Bloomega BioTechnology Facial Injectable Revenue in United States Market (2016-2021) 6.1.5 Bloomega BioTechnology Recent Developments 6.2 Allergan 6.2.1 Allergan Company Details 6.2.2 Allergan Business Overview 6.2.3 Allergan Facial Injectable Introduction 6.2.4 Allergan Facial Injectable Revenue in United States Market (2016-2021) 6.2.5 Allergan Recent Developments 6.3 Merz Pharma 6.3.1 Merz Pharma Company Details 6.3.2 Merz Pharma Business Overview 6.3.3 Merz Pharma Facial Injectable Introduction 6.3.4 Merz Pharma Facial Injectable Revenue in United States Market (2016-2021) 6.3.5 Merz Pharma Recent Developments 6.4 Bausch Health 6.4.1 Bausch Health Company Details 6.4.2 Bausch Health Business Overview 6.4.3 Bausch Health Facial Injectable Introduction 6.4.4 Bausch Health Facial Injectable Revenue in United States Market (2016-2021) 6.4.5 Bausch Health Recent Developments 6.5 Galderma 6.5.1 Galderma Company Details 6.5.2 Galderma Business Overview 6.5.3 Galderma Facial Injectable Introduction 6.5.4 Galderma Facial Injectable Revenue in United States Market (2016-2021) 6.5.5 Galderma Recent Developments 6.6 Integra Lifesciences 6.6.1 Integra Lifesciences Company Details 6.6.2 Integra Lifesciences Business Overview 6.6.3 Integra Lifesciences Facial Injectable Introduction 6.6.4 Integra Lifesciences Facial Injectable Revenue in United States Market (2016-2021) 6.6.5 Integra Lifesciences Recent Developments 6.7 Tei Biosciences 6.7.1 Tei Biosciences Company Details 6.7.2 Tei Biosciences Business Overview 6.7.3 Tei Biosciences Facial Injectable Introduction 6.7.4 Tei Biosciences Facial Injectable Revenue in United States Market (2016-2021) 6.7.5 Tei Biosciences Recent Developments 6.8 Fibrogen 6.8.1 Fibrogen Company Details 6.8.2 Fibrogen Business Overview 6.8.3 Fibrogen Facial Injectable Introduction 6.8.4 Fibrogen Facial Injectable Revenue in United States Market (2016-2021) 6.8.5 Fibrogen Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Facial Injectable Market Opportunities & Trends in United States Market Table 2. Facial Injectable Market Drivers in United States Market Table 3. Facial Injectable Market Restraints in United States Market Table 4. Key Players of Facial Injectable in United States Market Table 5. Top Facial Injectable Players in United States Market, Ranking by Revenue (2019) Table 6. United States Facial Injectable Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Facial Injectable Revenue Share by Companies, 2016-2021 Table 8. Companies Facial Injectable Product Type Table 9. List of Tier 1 Facial Injectable Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Facial Injectable Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – United States Facial Injectable Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Facial Injectable Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Facial Injectable Revenue (US$, Mn), 2022-2027 Table 14. By Application – United States Facial Injectable Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Facial Injectable Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Facial Injectable Revenue (US$, Mn), 2022-2027 Table 17. Bloomega BioTechnology Company Details Table 18. Bloomega BioTechnology Business Overview Table 19. Bloomega BioTechnology Facial Injectable Product Table 20. Bloomega BioTechnology Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million) Table 21. Bloomega BioTechnology Recent Developments Table 22. Allergan Company Details Table 23. Allergan Business Overview Table 24. Allergan Facial Injectable Product Table 25. Allergan Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million) Table 26. Allergan Recent Developments Table 27. Merz Pharma Company Details Table 28. Merz Pharma Business Overview Table 29. Merz Pharma Facial Injectable Product Table 30. Merz Pharma Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Merz Pharma Recent Developments Table 32. Bausch Health Company Details Table 33. Bausch Health Business Overview Table 34. Bausch Health Facial Injectable Product Table 35. Bausch Health Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Bausch Health Recent Developments Table 37. Galderma Company Details Table 38. Galderma Business Overview Table 39. Galderma Facial Injectable Product Table 40. Galderma Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Galderma Recent Developments Table 42. Integra Lifesciences Company Details Table 43. Integra Lifesciences Business Overview Table 44. Integra Lifesciences Facial Injectable Product Table 45. Integra Lifesciences Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million) Table 46. Integra Lifesciences Recent Developments Table 47. Tei Biosciences Company Details Table 48. Tei Biosciences Business Overview Table 49. Tei Biosciences Facial Injectable Product Table 50. Tei Biosciences Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million) Table 51. Tei Biosciences Recent Developments Table 52. Fibrogen Company Details Table 53. Fibrogen Business Overview Table 54. Fibrogen Facial Injectable Product Table 55. Fibrogen Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million) Table 56. Fibrogen Recent Developments List of Figures Figure 1. Facial Injectable Segment by Type Figure 2. Facial Injectable Segment by Application Figure 3. United States Facial Injectable Market Overview: 2020 Figure 4. United States Facial Injectable Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Facial Injectable Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Facial Injectable Revenue in 2020 Figure 7. By Type - United States Facial Injectable Revenue Market Share, 2016-2027 Figure 8. By Application - United States Facial Injectable Revenue Market Share, 2016-2027 Figure 9. Bloomega BioTechnology Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Allergan Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Merz Pharma Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Bausch Health Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Galderma Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Integra Lifesciences Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Tei Biosciences Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 16. Fibrogen Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Bloomega BioTechnology Allergan Merz Pharma Bausch Health Galderma Integra Lifesciences Tei Biosciences Fibrogen